Dose–response relationship between docosahexaenoic acid (DHA) intake and lower rates of early preterm birth, low birth weight and very low birth weight

As previously reported, intention-to-treat findings from our phase III randomized clinical trial found that a supplement of 600 mg docosahexaenoic acid (DHA)/day during the last half of pregnancy reduced the incidence of early preterm birth (ePTB,

Saved in:
Bibliographic Details
Published in:Prostaglandins, leukotrienes and essential fatty acids leukotrienes and essential fatty acids, 2018-11, Vol.138, p.1-5
Main Authors: Carlson, Susan E., Gajewski, Byron J., Alhayek, Sibelle, Colombo, John, Kerling, Elizabeth H., Gustafson, Kathleen M.
Format: Article
Language:English
Subjects:
Adult
Birth weight
Compliance
Dietary Supplements
Docosahexaenoic acid
Docosahexaenoic Acids - administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Infant, Newborn
Infant, Very Low Birth Weight
Placebo
Pregnancy
Premature Birth - prevention & control
Preterm birth
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As previously reported, intention-to-treat findings from our phase III randomized clinical trial found that a supplement of 600 mg docosahexaenoic acid (DHA)/day during the last half of pregnancy reduced the incidence of early preterm birth (ePTB,
ISSN:0952-3278
1532-2823
DOI:10.1016/j.plefa.2018.09.002